Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,101,583 papers from all fields of science
Search
Sign In
Create Free Account
A 56620
Known as:
A-56620
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
sarafloxacin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea
J. Bryan
,
C. Waters
,
J. Sheffield
,
R. Krieg
,
P. Perine
,
K. Wagner
Antimicrobial Agents and Chemotherapy
1990
Corpus ID: 21051376
Tosufloxacin (A-60969 HCl), a new quinolone with broad activity against gram-positive and anaerobic organisms, was compared in…
Expand
1989
1989
In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy
D. Sahm
,
G. T. Koburov
Antimicrobial Agents and Chemotherapy
1989
Corpus ID: 22902245
The MICs and MBCs of CI-934, ciprofloxacin, difloxacin (A-56619), A-56620, norfloxacin, enoxacin, amifloxacin, and coumermycin…
Expand
1988
1988
Synergistic interactions of ciprofloxacin and extended spectrum beta-lactams or aminoglycosides against Acinetobacter calcoaceticus ss. anitratus.
A. Chow
,
J. Wong
,
K. Bartlett
Diagnostic microbiology and infectious disease
1988
Corpus ID: 20182942
1987
1987
Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis
J. Mader
,
L. Morrison
,
K. Adams
Antimicrobial Agents and Chemotherapy
1987
Corpus ID: 25213741
A rabbit model for Staphylococcus aureus osteomyelitis was used to compare the results of treatment with A-56619 and A-56620, two…
Expand
1987
1987
Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro
M. Bansal
,
H. Thadepalli
Antimicrobial Agents and Chemotherapy
1987
Corpus ID: 19623427
We determined the MICs of difloxacin (A-56619) and A-56620 against anaerobic bacteria and assessed the effects of alterations in…
Expand
Highly Cited
1986
Highly Cited
1986
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones
J. Stamm
,
C. W. Hanson
,
D. Chu
,
R. Bailer
,
C. Vojtko
,
P. Fernandes
Antimicrobial Agents and Chemotherapy
1986
Corpus ID: 9828169
The in vitro antibacterial potencies of A-56619 and A-56620, two new aryl-fluoroquinolones, were compared with the potency of…
Expand
1986
1986
Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620
L. Hirschhorn
,
H. Neu
Antimicrobial Agents and Chemotherapy
1986
Corpus ID: 27161427
The in vitro activity of difloxacin (A-56619) and A-56620, two new aryl-difluoroquinolones, was decreased by magnesium at 9 mM…
Expand
1986
1986
In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens
W. Bowie
,
C. Shaw
,
D. G. Chan
,
J. Boyd
,
W. Black
Antimicrobial Agents and Chemotherapy
1986
Corpus ID: 6703540
Management of sexually transmitted diseases is facilitated by having antimicrobial agents with activity against all of the major…
Expand
1986
1986
Comparison of susceptibility of gentamicin-resistant and -susceptible "Acinetobacter anitratus" to 15 alternative antibiotics
H. Stiver
,
K. Bartlett
,
A. Chow
Antimicrobial Agents and Chemotherapy
1986
Corpus ID: 40322455
Fifty-four clinical isolates of "Acinetobacter anitratus" separated cleanly into gentamicin-susceptible (16 strains) and…
Expand
Highly Cited
1985
Highly Cited
1985
In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620
G. Eliopoulos
,
A. E. Moellering
,
E. Reiszner
,
R. Moellering
Antimicrobial Agents and Chemotherapy
1985
Corpus ID: 41772662
The in vitro activities of two new quinolone antimicrobial agents, A-56619 and A-56620, were compared with those of norfloxacin…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE